Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,892.00
Bid: 1,896.00
Ask: 1,902.00
Change: 12.00 (0.64%)
Spread: 6.00 (0.316%)
Open: 1,876.00
High: 1,910.00
Low: 1,876.00
Prev. Close: 1,880.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus' ABS unit has 'challenging start' to FY, PIC trading remains 'robust'

Wed, 22nd Nov 2023 10:13

(Sharecast News) - Animal genetics firm Genus said its ABS division has had "a challenging start" to the year but noted that PIC trading in the roughly five months ended 21 November had been "robust".

Genus said on Wednesday that PIC saw year-on-year growth in both volumes and royalty revenues. While it was "relatively insulated" from US producer losses caused by low pig prices, and also "performed well" in Latin America and Europe, pig prices in China continued to be depressed and the majority of producers in the Asian nation remained loss-making.

"This compares with a relatively strong period for Chinese pork prices in the equivalent period last year. Against this strong comparator, PIC Asia's adjusted operating profit was lower than the prior year," said Genus.

The FTSE 250-listed firm also said ABS made a rough start to the year, with lower year-on-year volumes being partially offset by improvements in prices and mix. Genus said ABS' adjusted operating profit was lower than the prior year but noted there were "significant operational improvements underway" within ABS which it expects to drive improved adjusted operating profit performance for the full year.

"As anticipated, R&D costs in the period were higher year-on-year, reflecting the annualised operating cost impact of Atlas, PIC's new nucleus farm, and expenditure in relation to PRRS Resistant Pig commercialisation," said Genus.

As of 1010 GMT, Genus shares were down 3.13% at 2,046.0p.

Reporting by Iain Gilbert at Sharecast.com

More News
25 Feb 2021 09:05

Genus reports strong interim results

(Sharecast News) - Animal genetics company Genus reported a record adjusted profit before tax in its interim results on Thursday, as revenue in its porcine genetics business 'PIC' rose 8%.

Read more
18 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Jan 2021 11:59

LONDON MARKET MIDDAY: US Holiday Leads To Quiet Session; Airlines Slip

LONDON MARKET MIDDAY: US Holiday Leads To Quiet Session; Airlines Slip

Read more
18 Jan 2021 09:34

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

UK BROKER RATINGS SUMMARY: Land Securities And Dixons Get Upgrades

Read more
18 Jan 2021 08:40

LONDON MARKET OPEN: Soft Start As China Retail Sales Signal Weakness

LONDON MARKET OPEN: Soft Start As China Retail Sales Signal Weakness

Read more
18 Jan 2021 08:35

Genus Set To Post Strong Interim Growth, Beat Prior Annual Guidance

Genus Set To Post Strong Interim Growth, Beat Prior Annual Guidance

Read more
18 Jan 2021 07:43

LONDON MARKET PRE-OPEN: Spirent Expects Earnings Growth For 2020

LONDON MARKET PRE-OPEN: Spirent Expects Earnings Growth For 2020

Read more
4 Dec 2020 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
2 Dec 2020 08:40

Covid-19 vaccines trigger new bullmarket, Liberum says

(Sharecast News) - The development of successful Covid-19 vaccines has set off a fresh bull market for UK shares that will last several years, Liberum analysts said.

Read more
25 Nov 2020 13:38

Wednesday broker round-up

(Sharecast News) - Codemasters Group: Berenberg downgrades to hold with a target price of 485p.

Read more
25 Nov 2020 11:56

LONDON MARKET MIDDAY: Pre-Thanksgiving Markets Lull; Sunak Review Due

LONDON MARKET MIDDAY: Pre-Thanksgiving Markets Lull; Sunak Review Due

Read more
25 Nov 2020 10:44

UK WINNERS & LOSERS SUMMARY: GoCo Up, Future Down After Takeover Offer

UK WINNERS & LOSERS SUMMARY: GoCo Up, Future Down After Takeover Offer

Read more
25 Nov 2020 10:10

Genus Reports Strong Trading Growth Depsite Covid-19 Pandemic Impact

Genus Reports Strong Trading Growth Depsite Covid-19 Pandemic Impact

Read more
25 Nov 2020 09:28

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

UK BROKER RATINGS SUMMARY: Jefferies Upgrades Antofagasta And Glencore

Read more
25 Nov 2020 08:31

Genus sees 'good momentum' carry over into new trading year

(Sharecast News) - Animal genetics company Genus said on Wednesday that "good momentum" seen at the end of the previous trading year had carried over into the current one.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.